Compare · AVTR vs OLK
AVTR vs OLK
Side-by-side comparison of Avantor Inc. (AVTR) and Olink Holding AB (OLK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AVTR and OLK operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
- AVTR carries a market cap of $6.25B.
- AVTR has hit the wire 14 times in the past 4 weeks while OLK has been quiet.
- AVTR has more recent analyst coverage (25 ratings vs 3 for OLK).
- Company
- Avantor Inc.
- Olink Holding AB
- Price
- $9.15+8.93%
- $26.01+0.04%
- Market cap
- $6.25B
- -
- 1M return
- +16.41%
- -
- 1Y return
- -29.75%
- -
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2021
- News (4w)
- 14
- 0
- Recent ratings
- 25
- 3
Avantor Inc.
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Olink Holding AB
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. The company's products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. In addition, it provides Olink normalized protein expression (NPX) Manager, a purpose-built software that enable users to import data, validate data quality, and normalize for subsequent statistical analysis; and Olink Insight, a cloud platform for data visualization and statistical analysis of NPX data. Olink Holding AB (publ) sells its products and services through its own direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. The company was founded in 2004 and is headquartered in Uppsala, Sweden. Olink Holding AB (publ) is a subsidiary of Summa Equity Holding AB.
Latest AVTR
- Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
- RBC Capital Mkts resumed coverage on Avantor with a new price target
- Avantor Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Murthy Mala was granted 25,270 shares, increasing direct ownership by 57% to 69,479 units (SEC Form 4)
- Director Lucier Gregory T was granted 25,270 shares and bought $83,200 worth of shares (10,000 units at $8.32), increasing direct ownership by 289% to 34,006 units (SEC Form 4)
- Director Dingemans Simon was granted 25,270 shares, increasing direct ownership by 406% to 31,495 units (SEC Form 4)
- Director Massaro Joseph R was granted 25,270 shares, increasing direct ownership by 48% to 77,408 units (SEC Form 4)
- Director Makin Louise was granted 25,270 shares, increasing direct ownership by 116% to 47,140 units (SEC Form 4)
- Director Mehra Sanjeev K was granted 25,270 shares, increasing direct ownership by 312% to 33,376 units (SEC Form 4)
- Director Severino Michael was granted 25,270 shares, increasing direct ownership by 42% to 85,821 units (SEC Form 4)
Latest OLK
- SEC Form 15F-12B filed by Olink Holding AB
- SEC Form 6-K filed by Olink Holding AB
- Amendment: SEC Form SC 14D9/A filed by Olink Holding AB
- Amendment: SEC Form SC TO-T/A filed by Olink Holding AB
- SEC Form 6-K filed by Olink Holding AB
- Notice to attend the Extra General Meeting of Olink Holding AB (publ)
- SEC Form 6-K filed by Olink Holding AB
- SEC Form S-8 POS filed by Olink Holding AB
- SEC Form S-8 POS filed by Olink Holding AB
- SEC Form S-8 POS filed by Olink Holding AB